Thalidomide-O-amido-C3-COOH structure
|
Common Name | Thalidomide-O-amido-C3-COOH | ||
|---|---|---|---|---|
| CAS Number | 2308035-51-8 | Molecular Weight | 417.370 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | 833.7±65.0 °C at 760 mmHg | |
| Molecular Formula | C19H19N3O8 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 458.0±34.3 °C | |
Use of Thalidomide-O-amido-C3-COOHThalidomide-O-amido-C3-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology. |
| Name | E3 ligase Ligand-Linker Conjugates 15 |
|---|---|
| Synonym | More Synonyms |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 833.7±65.0 °C at 760 mmHg |
| Molecular Formula | C19H19N3O8 |
| Molecular Weight | 417.370 |
| Flash Point | 458.0±34.3 °C |
| Exact Mass | 417.117218 |
| LogP | -1.05 |
| Vapour Pressure | 0.0±3.2 mmHg at 25°C |
| Index of Refraction | 1.616 |
| 4-[({[2-(2,6-Dioxo-3-piperidinyl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}acetyl)amino]butanoic acid |
| Butanoic acid, 4-[[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]acetyl]amino]- |